Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

WFNOS Magazine

The inaugural issue of the official publication of the World Federation of Neuro-Oncology Societies is ...

Read Full Story

Neuro-Oncology Review Course at SNO

November 16, 2016. Register in conjunction with the SNO Annual Meeting

Read Full Story

CNS Anticancer Drug Discovery and Development Conference

Register Now!

Read Full Story
View All News


EANO 2016

Read Full Story


18th Annual Brain Tumor Update and 7th Annual International Symposium on Long-Term Control of Metastases to the Brain and Spine

Read Full Story


2nd CNS Anticancer Drug Discovery/Development Conference

Read Full Story

Washington University School of Medicine

Washington University School of Medicine
Department of Neurology
Box 8111, 660 S. Euclid Ave.
St. Louis, MO  63110

David H. Gutmann, M.D., Ph.D.

Research Categories:

    -Basic science research
    -Translational research

Research Interests/projects:

The development of the mammalian brain is a highly regulated process involving both cell-autonomous and non-cell-autonomous decisions that determine cell fate, proliferation, migration and death. The genes that govern these critical decisions are often mutated in human cancers, and their de-regulated function in the central nervous system (CNS) leads to the development of brain tumors. Our laboratory is interested in understanding the key signals that control normal neural stem cell (NSC) and glial cell growth and differentiation in vitro and in vivo. To this end, we study the genes mutated in the two cancer predisposition syndromes, neurofibromatosis 1 (NF1) and neurofibromatosis 2 (NF2), in which affected individuals develop brain tumors. We have generated numerous genetically-engineered mouse models to explore the relationship between developmental neurobiology (normal growth regulation in the brain) and neuro-oncology (brain tumor formation).  Current projects in the laboratory focus on (1) dissecting the key signaling pathways that drive tumor cell growth, (2) defining the role of the tumor microenvironment, (3) elucidating the impact of cancer-causing genetic changes on neural stem cell function, and (4) using genetically-engineered mouse models of brain tumors to study disease pathogenesis and novel treatment strategies.